OMEGA HEALTH SYSTEMS INC
8-K, 1996-05-31
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: EUROPEAN WARRANT FUND INC, N-30D, 1996-05-31
Next: HALLWOOD REALTY PARTNERS L P, SC 13D/A, 1996-05-31






                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported): May 17, 1996


                           OMEGA HEALTH SYSTEMS, INC.
             (Exact name of registrant as specified in its charter)


                                    Delaware
                 (State or other jurisdiction of incorporation)


                                     0-19283
                            (Commission File Number)


                                   63-0858713
                      (I.R.S. Employer Identification No.)


            5100 Poplar Avenue, Suite 2100, Memphis, Tennessee     38137
               (Address of principal executive offices)          (Zip Code)


        Registrant's telephone number, including area code: 901-683-7868


                                 Not applicable
              (Former name, former address and former fiscal year,
                          if changed since last report)
















                                       1

<PAGE>


                    INFORMATION TO BE INCLUDED IN THE REPORT

Item 5.  Other Events.

On  March  17,  1996,  the  Registrant  completed  the  sale  of  $7,290,000  in
convertible preferred stock. Subject to certain limitations, the preferred stock
is convertible into the Registrant's  common stock at an exercise price equal to
the lesser of $5.75 or 85% of the average bid price of the  Registrant's  common
stock at the time of conversion.  The preferred stock has a dividend rate of 8%,
which  is paid in the  form of  common  stock  at the  time of  conversion.  The
preferred stock automatically converts to common stock at the end of three years
if not already  converted.  In  addition,  the  investors  received  warrants to
purchase approximately 634,000 additional shares at an exercise price of $5.75.

The net proceeds  were  approximately  $6.56 million will be used to finance the
acquisition of eye care practices and for working capital.

Item 7.  Exhibits.

         2.1      Press Release dated May 21, 1996


































                                       2

<PAGE>


SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                           OMEGA HEALTH SYSTEMS, INC.


Date:  May 31, 1996        By: /s/Ronald L.Edmonds
                           ------------------------
                           Ronald L. Edmonds
                            Senior Vice President and Chief Financial Officer






































                                       3








                                   Exhibit 2.1

                        Press Release Dated May 21, 1996











































<PAGE>


                                  PRESS RELEASE

FOR IMMEDIATE RELEASE

Queries:      Thomas P. Lewis, President & CEO                901-683-7868
              Ronald  L. Edmonds, Senior Vice President & CFO 901-683-7868
              Steven Kessler, Howard Bronson & Company, Inc.  212-867-6160

                    OMEGA COMPLETES SALE OF PREFERRED STOCK,
                          PLANS ADDITIONAL ACQUISITIONS

Memphis,  Tennessee -- May 21, 1996 -- Omega Health Systems, Inc. (NASDAQ: OHSI)
today  announced  that it had completed the sale of $7.29 million in convertible
preferred  stock.  The  proceeds  of the  offering  will be used to finance  the
acquisition of the assets of eye care practices and for working capital.

The net proceeds of $6.56  million will be used to finance  Omega's  acquisition
program.  Omega has completed the acquisition of the assets of two ophthalmology
practices so far this year and  anticipates  completing at least four additional
acquisitions by year end. Omega currently has letters of intent covering a major
acquisition  in North  Texas and three  additional  practices.  The  Company  is
optimistic  that, in the future,  it will continue to achieve its  objectives of
effecting  long  term  growth,   through  the  completion  of  other   strategic
acquisitions.

Subject to certain  limitations,  the preferred stock is convertible  into Omega
common  stock at an  exercise  price  equal to the lesser of $5.75 or 85% of the
average bid price at the time of conversion.  The preferred stock has a dividend
rate of 8%, which is paid in the form of common stock at the time of conversion.
The  preferred  stock  automatically  converts  at the end of three years if not
already  converted.  In addition,  the investors  received  warrants to purchase
approximately 634,000 additional shares at an exercise price of $5.75.

Omega  Health  Systems is a  physician  practice  management  company  providing
comprehensive  eye care  services  through  an  expanding  nationwide  system of
medical eye centers,  managed care provider networks,  eye surgical  facilities,
excimer laser refractive  surgery programs and an opthalmic  specialty  supplies
and equipment distribution company.


                                       5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission